Logan Dumitrescu 1 , Cara L. Carty 2 , Kira Taylor 3 , Fredrick R. Schumacher 4 , Lucia A. Hindorff 5 , José L. Ambite 6 , Garnet Anderson 2 , Lyle G. Best 7 , Kristin Brown-Gentry 1 , Petra Bůžková 8 , Christopher S. Carlson 2 , Barbara Cochran 9 , Shelley A. Cole 10 , Richard B. Devereux 11 , Dave Duggan 12 , Charles B. Eaton 13 , Myriam Fornage 14 , 15 , Nora Franceschini 3 , Jeff Haessler 2 , Barbara V. Howard 16 , Karen C. Johnson 17 , Sandra Laston 10 , Laurence N. Kolonel 18 , Elisa T. Lee 19 , Jean W. MacCluer 10 , Teri A. Manolio 5 , Sarah A. Pendergrass 1 , Miguel Quibrera 20 , Ralph V. Shohet 21 , Lynne R. Wilkens 18 , Christopher A. Haiman 4 , Loïc Le Marchand 18 , Steven Buyske 22 , Charles Kooperberg 2 , Kari E. North 3 , 23 , Dana C. Crawford 1 , 24 , *
30 June 2011
For the past five years, genome-wide association studies (GWAS) have identified hundreds of common variants associated with human diseases and traits, including high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglyceride (TG) levels. Approximately 95 loci associated with lipid levels have been identified primarily among populations of European ancestry. The Population Architecture using Genomics and Epidemiology (PAGE) study was established in 2008 to characterize GWAS–identified variants in diverse population-based studies. We genotyped 49 GWAS–identified SNPs associated with one or more lipid traits in at least two PAGE studies and across six racial/ethnic groups. We performed a meta-analysis testing for SNP associations with fasting HDL-C, LDL-C, and ln(TG) levels in self-identified European American (∼20,000), African American (∼9,000), American Indian (∼6,000), Mexican American/Hispanic (∼2,500), Japanese/East Asian (∼690), and Pacific Islander/Native Hawaiian (∼175) adults, regardless of lipid-lowering medication use. We replicated 55 of 60 (92%) SNP associations tested in European Americans at p<0.05. Despite sufficient power, we were unable to replicate ABCA1 rs4149268 and rs1883025, CETP rs1864163, and TTC39B rs471364 previously associated with HDL-C and MAFB rs6102059 previously associated with LDL-C. Based on significance (p<0.05) and consistent direction of effect, a majority of replicated genotype-phentoype associations for HDL-C, LDL-C, and ln(TG) in European Americans generalized to African Americans (48%, 61%, and 57%), American Indians (45%, 64%, and 77%), and Mexican Americans/Hispanics (57%, 56%, and 86%). Overall, 16 associations generalized across all three populations. For the associations that did not generalize, differences in effect sizes, allele frequencies, and linkage disequilibrium offer clues to the next generation of association studies for these traits.
Low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride (TG) levels are well known independent risk factors for cardiovascular disease. Lipid-associated genetic variants are being discovered in genome-wide association studies (GWAS) in samples of European descent, but an insufficient amount of data exist in other populations. Therefore, there is a strong need to characterize the effect of these GWAS–identified variants in more diverse cohorts. In this study, we selected over forty genetic loci previously associated with lipid levels and tested for replication in a large European American cohort. We also investigated if the effect of these variants generalizes to non-European descent populations, including African Americans, American Indians, and Mexican Americans/Hispanics. A majority of these GWAS–identified associations replicated in our European American cohort. However, the ability of associations to generalize across other racial/ethnic populations varied greatly, indicating that some of these GWAS–identified variants may not be functional and are more likely to be in linkage disequilibrium with the functional variant(s).